Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer 英文论文文献.docVIP

  • 5
  • 0
  • 约5.93万字
  • 约 13页
  • 2017-05-08 发布于上海
  • 举报

Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer 英文论文文献.doc

Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer 英文论文文献

Westetal.BreastCancerResearch2011,13:R126 /content/13/6/R126 RESEARCH ARTICLE OpenAccess Tumor-infiltratinglymphocytespredictresponse toanthracycline-basedchemotherapyinestrogen receptor-negativebreastcancer NathanRWest1,2,KatyMilne1,PaulineTTruong3,NicolMacpherson4,BradHNelson1,2,5,6 andPeterHWatson1,2,7* Abstract Introduction:Infiltrationofbreasttumorsbytumor-infiltratinglymphocytes(TIL)hasbeenassociatedwith sensitivitytoanthracycline-basedchemotherapy.However,itisunclearwhetherthisistruewithintheestrogen receptor-alpha(ER)-negativesubsetofbreasttumorsthatfrequentlymanifesthighTILle

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档